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在反应时间为 2 h、温度为 20~40℃、壳聚糖浓度为 0.1~20 g/L、抗坏血酸/ Na2SeO3
比值为 5:1 至 40:1 之间时，制备的纳米硒颗粒呈规则球形，且分散均匀，粒径为
60 nm 左右。优化的交联条件为：交联比为 500:330（质量比）、交联时间为 2 h、
温度为 30℃。壁材的交联效果良好，碳元素和硫元素的化学计量比为 2.2:1 以下，




包埋纳米硒（总硒含量为1.47 mg/g）对昆明种小鼠的急性毒性LD50为203 mg 
Se/KgBW，95%置信区间为 180~229mg Se/KgBW，安全性明显高于亚硒酸钠























Synthesis, Characterization and Activities Study of 
Nano-selenium Embedded by Marine-derived 
Amino-polysaccharide 
Abstract 
Selenium (Se) as a dietary nutrient is an essential trace element in animals and 
human being. Neither selenium-deficiency nor selenium-excess would be beneficial to 
health. Most of the reagions in the world, especially China were lack of selenium 
supplyment from food. The study and development of health food rich of selenium 
would gain a promising expectation due to the huge- but long-term market-demand of 
this kind of food. 
Nano-selenium is a type of elemental selenium with nano-size, possessing the 
ability to supply selenium to human body with low toxicity. The bio-safety of 
selenium to human body would be improved by nano-Se. Thus the study on nano-Se 
becomes one of the most important prospects when developing selenium supplement 
with high efficiency but limited toxic effects. In this work chitosan as a kind of 
marine amino-polysaccharides, acted as template and dispersing agent and provided 
the space for the reductional reaction of selenium with high valence state. As a result, 
nano-Se colloid was synthesized. Subsequently ionic gelation method was used to 
prepare cross-linked chitosan to encapsulate nano-Se particles. Finally a series of 
chitosan-coated nano-Se were created, of which composed the nano-Se core and the 
sulfuric acid-crosslinked chitosan membrane.  
The influencing factors on synthesis, such as reaction time, temperature, and 
reagants’ concentration were studied. The optimizational reaction condition was: 
reacted for 2 hous, 20-40℃, 0.1-20 g/L of chitosan and the ratio of Vitamine 
C/sodium selenite ranged from 5:1 to 40:1. The coming nano-Se nanoparticals were 
regular spheroids with a diameter about 60 nm, dispersing in the colloid. The 
recommendatory technical parameters of the cross-linking reaction were: reacted for 2 
hours, 30℃ and the weight-ratio of chitosan to sodium sulfate as 500:330. The 
cross-linking effect was consistent with the expectation. The stoichiometry of C to N 
was less than 2.2:1. The embedding rates of selenium by cross-linked chitosan were 
never less than 83%. TEM, SEM, EDS and XPS results confirmed the elemental 
selenium nature of nano-Se. The results demonstrated the nano-Se nanoparticles were 















chitosan membrane. The size of nano-Se remained less than 100 nm even after the 
embedding process. To sum up, the chitosan-coated nano-Se was practicable for 
industrial production due to its stable but adjustable selenium-content and its high 
embedding rates and its controllable contamination and its simple productive process. 
  The LD50 value of chitosan-coated nano-Se (containing 1.47 mg Se/g) against 
Kunming mice was 203 mg Se/Kg BW, with 95% confidence limits as 180-229 mg 
Se/Kg BW while the LD50 value of sodium selenite was 9.69 mg Se/Kg BW. 
Chitosan-coated nano-Se showed more high security than sodium selenite. The value 
of cumulative coefficient K excessed 5, indicating that the cumulative effect of 
chitosan-coated nano-Se was weak. Chitosan-coated nano-Se had more bio-safty than 
sodium selenite. 
  In conclusion, our work offered a new insight into the development of nano-Se, 
particularly the nano-Se with proprietary intellectual property rights, aiming to 
possesses exert high efficiency and low toxicity pharmacological activity. The results 
of this work will also benefit the further investigation on the development of natural 
amino-polysaccharides in particular chitosan. 
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Berzelius 于 1817 年发现的。硒属氧族元素，原子序数为 34，其化学性质介于金
属和非金属之间，性质与硫相似，但金属性比硫强，是典型的半金属元素。 
由于人类对硒的认识有限，硒元素一度被认为是对人体没有任何生物活性、
只有毒性的“有害”元素。1957 年美国营养学家 Schwarz 和 Foltz 首次用硒治疗
动物肝坏死取得成功以后，硒才被逐渐确定为动物体内必需的微量元素[1,2]。我
国在 20 世纪 70 年代通过对克山病的流行病学调查，也证实了硒是人体的一种必
需微量元素[3]。1973 年，硒被世界卫生组织（WHO）确定为人体所必需的 14 种
微量元素之一[4]。1988 年 10 月，中国营养学会修订的“每日膳食营养素供给量”




























































并分离的硒蛋白有 35 种，其中功能比较明确的有 GSH-Px、脱碘酶、脂氢过氧

































































































































































图 1-1 动物体和人体中硒的可能代谢途径（由 Whanger P.D.[36]提供） 


























































































般膳食硒供应量在 50~250 μg 范围，400μg 作为日 大安全膳食硒摄入量，恩施
高硒区则暂用 550 μg。1988 年，中国营养学会针对不同的人群制定了硒的摄入
标准[54,55]。建议摄入的硒源为亚硒酸钠时，对于成年人群硒的可耐受 高摄入量
为 400 μg /d，推荐摄入量为成人 50~250 μg/d，儿童为 20~50 μg/d，普通癌症患
者为 200~400 μg/d，化疗过程中可增至 400~900 μg/d（表 1-1）[55]。 
表 1-1 中国营养学会推荐的补硒参考标准 
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